Synergistic Infection Prevention and Treatment Systems

The present invention integrates vaccines, antibiotics, and anti-viral drugs with advanced technologies like AI, IoT, blockchain, and hybrid materials to create a powerful system for preventing and treating infections.

The original patent disclosed methods for treating infections using drug and vaccination combination treatments. However, the patent's limitations include the lack of integration with advanced technologies, which can enhance the effectiveness and efficiency of infection prevention and treatment. The new inventive concept addresses this limitation by combining the original patent's methods with cutting-edge technologies to create a more comprehensive and powerful system.

The synergistic infection prevention and treatment system comprises a vaccine directed to a causative agent of an infection, an anti-microbial drug combination capable of killing the infection, and one or more advanced technologies such as AI, IoT, blockchain, or hybrid materials. The AI-assisted personalized medicine embodiment uses machine learning algorithms to predict and prevent vaccine breakthrough infections. The IoT-based monitoring system detects and responds to early signs of infection. The blockchain-based tracking system monitors and prevents in vivo mutations of the infection's causative agent. The hybrid material-based vaccine and anti-microbial drug combination embodiment utilizes a vaccine with enhanced immunogenic properties. These synergistic combinations enhance the effectiveness and efficiency of infection prevention and treatment.

The new claims introduce the integration of advanced technologies with the original patent's methods, which is novel and non-obvious. The specific combinations of technologies and the ways they interact to prevent and treat infections are inventive steps that distinguish the new inventive concept from the original patent.

Alternative embodiments may include using different AI algorithms, IoT devices, or blockchain platforms. Variations may include integrating additional technologies, such as nanotechnology or gene editing, to further enhance the system's effectiveness.

The synergistic infection prevention and treatment system has significant commercial potential in the healthcare industry, particularly in the areas of infectious disease prevention and treatment. The system can be marketed to hospitals, clinics, and pharmaceutical companies, and may also have applications in veterinary medicine and biodefense.